Tag Archives: Breaking News: Trade

Promising Covid acquires Merk On Nocoimun for drug supply

Pharmaceutical giant Merck said it plans to acquire privately held Oncoimmune for 42 5,425 million in cash, which would entitle the under-the-radar drug, which has shown shocking results for hospitalized patients with Covid-19. In a phase-by-clinical study in late September, a drug called CD24FC was shown to reduce the risk …

Read More »